0.5298USD-4.00%Mkt Cap: 6.49M $P/E: —1d ago
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detect…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap6.49M $
Enterprise Value2.77M $
Revenue (TTM)1.84M $
Gross Profit604.54K $
Net Income (TTM)-3.74M $
Revenue/Share0.3270 USD
Last Price0.5298 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.71
EV/Revenue1.50
P/S3.52
P/B2.17
EPS (TTM)-0.49
EPS (Forward)—
52W Range
0.51010% of range50.00
52W High50.00 USD
52W Low0.5101 USD
Profitability
Gross Margin29.56%
Oper. Margin-408.45%
EBITDA Margin-212.60%
Profit Margin-182.82%
ROE19447.70%
ROA-90.37%
Growth
Revenue Growth-36.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.92M $
CapEx (TTM)—
FCF Margin-70.58%
FCF Yield-20.06%
Net Debt-3.29M $
Net Debt/EBITDA0.84
Balance Sheet
Debt/Equity-70.67
Current Ratio1.82
Quick Ratio1.71
Book Value/Sh0.2440 USD
Cash/Share0.3980 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.000 USD
Upside (mean)+843.8%
Target Range5.000 USD – 5.000 USD
# Analysts1
Ownership
Shares Out.12.25M
Float8.69M
Insiders26.16%
Institutions2.50%
Short Interest
Short Ratio0.1d
Short % Float1.84%
Short % Out.1.53%
Shares Short186.86K
Short (prev mo.)128.78K
Technical
SMA 500.9068 (-41.6%)
SMA 2002.041 (-74.0%)
Beta—
S&P 52W Chg20.25%
Avg Vol (30d)384.99K
Avg Vol (10d)346.02K
Technical Indicators
RSI (14)30.6
MACD-0.1036
MACD Signal-0.1263
MACD Hist.+0.0228
BB Upper0.6584 USD
BB Middle0.5916 USD
BB Lower0.5248 USD
BB Width22.60%
ATR (14)0.0816 USD
Vol Ratio (20d)0.27x